A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

Kamlesh Gidwani, Kaisa Huhtinen, Henna Kekki, Sandra van Vliet, Johanna Hynninen, Niina Koivuviita, Anti Perheentupa, Matti Poutanen, Annika Auranen, Seija Grenman, Urpo Lamminmaki, Olli Carpen, Yvette van Kooyk, Kim Pettersson

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1390-1400
JournalClinical Chemistry
Volume62
Issue number10
DOIs
Publication statusPublished - Oct 2016

Cite this

Gidwani, Kamlesh ; Huhtinen, Kaisa ; Kekki, Henna ; van Vliet, Sandra ; Hynninen, Johanna ; Koivuviita, Niina ; Perheentupa, Anti ; Poutanen, Matti ; Auranen, Annika ; Grenman, Seija ; Lamminmaki, Urpo ; Carpen, Olli ; van Kooyk, Yvette ; Pettersson, Kim. / A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources. In: Clinical Chemistry. 2016 ; Vol. 62, No. 10. pp. 1390-1400.
@article{c48b0cf6ebd0403e96b5fa30dd43e524,
title = "A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources",
author = "Kamlesh Gidwani and Kaisa Huhtinen and Henna Kekki and {van Vliet}, Sandra and Johanna Hynninen and Niina Koivuviita and Anti Perheentupa and Matti Poutanen and Annika Auranen and Seija Grenman and Urpo Lamminmaki and Olli Carpen and {van Kooyk}, Yvette and Kim Pettersson",
year = "2016",
month = "10",
doi = "10.1373/clinchem.2016.257691",
language = "English",
volume = "62",
pages = "1390--1400",
journal = "Clinical Chemistry",
issn = "0009-9147",
number = "10",

}

Gidwani, K, Huhtinen, K, Kekki, H, van Vliet, S, Hynninen, J, Koivuviita, N, Perheentupa, A, Poutanen, M, Auranen, A, Grenman, S, Lamminmaki, U, Carpen, O, van Kooyk, Y & Pettersson, K 2016, 'A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources' Clinical Chemistry, vol. 62, no. 10, pp. 1390-1400. https://doi.org/10.1373/clinchem.2016.257691

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources. / Gidwani, Kamlesh; Huhtinen, Kaisa; Kekki, Henna; van Vliet, Sandra; Hynninen, Johanna; Koivuviita, Niina; Perheentupa, Anti; Poutanen, Matti; Auranen, Annika; Grenman, Seija; Lamminmaki, Urpo; Carpen, Olli; van Kooyk, Yvette; Pettersson, Kim.

In: Clinical Chemistry, Vol. 62, No. 10, 10.2016, p. 1390-1400.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

AU - Gidwani, Kamlesh

AU - Huhtinen, Kaisa

AU - Kekki, Henna

AU - van Vliet, Sandra

AU - Hynninen, Johanna

AU - Koivuviita, Niina

AU - Perheentupa, Anti

AU - Poutanen, Matti

AU - Auranen, Annika

AU - Grenman, Seija

AU - Lamminmaki, Urpo

AU - Carpen, Olli

AU - van Kooyk, Yvette

AU - Pettersson, Kim

PY - 2016/10

Y1 - 2016/10

U2 - 10.1373/clinchem.2016.257691

DO - 10.1373/clinchem.2016.257691

M3 - Article

VL - 62

SP - 1390

EP - 1400

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 10

ER -